| Literature DB >> 23814599 |
Jung Su Lee1, Ho Cheol Kim, Sang Woo Park, Hoon Sub So, Chang Yun Woo, Jong Han Choi, Sang Hyung Kim, Se Jin Kim, Yeon-Mok Oh.
Abstract
Mucormycosis is a rare fungal disease that holds a fatal opportunistic fungal infection in diabetes mellitus, hematological malignancy, and immunocompromised host. Isolated pulmonary mucormycosis is extremely rare. Optimal therapy is a combined medical-surgical approach and a management of the patient's underlying disease. Herein, we report a case-study of isolated pulmonary mucormycosis which was being presented as multiple lung nodules in a patient with no underlying risk factors. Considering that the patient had poor pulmonary functions, we treated him with only antifungal agent rather than a combined medical-surgical approach. After treatment with antifungal agent for six months, the nodules of pulmonary mucormycosis were improved with the prominent reductions of size on the computed tomography.Entities:
Keywords: Immunocompetence; Lung; Mucormycosis; Posaconazole
Year: 2013 PMID: 23814599 PMCID: PMC3695309 DOI: 10.4046/trd.2013.74.6.269
Source DB: PubMed Journal: Tuberc Respir Dis (Seoul) ISSN: 1738-3536